Identification of Novel Markers of Human Lung Disease

Last updated: October 11, 2023
Sponsor: Ohio State University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

novel biomarkers of lung disease

Clinical Study ID

NCT02369575
2014H0367
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to investigate new therapies for advanced lung disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • any one on lung transplant list

Exclusion

Exclusion Criteria:

  • HIV positive

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: novel biomarkers of lung disease
Phase:
Study Start date:
February 01, 2015
Estimated Completion Date:
February 28, 2030

Study Description

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.

Connect with a study center

  • Davis Heart and Lung Research Institute

    Columbus, Ohio 43210
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.